BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35320850)

  • 21. Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.
    Locati LD; Galbiati D; Calareso G; Alfieri S; Singer S; Cavalieri S; Bergamini C; Bossi P; Orlandi E; Resteghini C; Platini F; Granata R; Quattrone P; Mancinelli M; Mariani L; Lo Vullo S; Licitra LF
    Cancer; 2020 Jan; 126(9):1888-1894. PubMed ID: 32031693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic therapy in the palliative management of advanced salivary gland cancers.
    Laurie SA; Licitra L
    J Clin Oncol; 2006 Jun; 24(17):2673-8. PubMed ID: 16763282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
    Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
    Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
    Warner KA; Oklejas AE; Pearson AT; Zhang Z; Wu W; Divi V; Rodriguez-Ramirez C; Castilho RM; Polverini PJ; Nör JE
    Oral Oncol; 2018 Dec; 87():21-28. PubMed ID: 30527239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland.
    Krucoff KB; Shammas RL; Stoecker M; Tolnitch LA
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30068574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Salivary gland cancer: new therapeutic approaches].
    Herrera Gomez RG; Mederos N; Szturz P; Degrauwe N; Jankovic J; Cristina V
    Rev Med Suisse; 2023 May; 19(827):958-963. PubMed ID: 37195109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
    Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG
    Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. As2O3 may be a treatment option for adenoid cystic carcinoma of salivary gland.
    Fu ZC; Zhang B; Fu ZJ
    Med Hypotheses; 2010 Dec; 75(6):490-1. PubMed ID: 20656411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland.
    Airoldi M; Pedani F; Brando V; Gabriele P; Giordano C
    Tumori; 1989 Jun; 75(3):252-6. PubMed ID: 2475951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
    Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma.
    Ge MH; Chen C; Xu JJ; Ling ZQ
    Hum Pathol; 2011 Dec; 42(12):1862-72. PubMed ID: 21658745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance.
    Skalova A; Leivo I; Hellquist H; Agaimy A; Simpson RHW; Stenman G; Vander Poorten V; Bishop JA; Franchi A; Hernandez-Prera JC; Slouka D; Willems SM; Olsen KD; Ferlito A
    Adv Anat Pathol; 2021 May; 28(3):107-118. PubMed ID: 33825717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
    Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
    Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.
    Elkin AD; Jacobs CD
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1151-3. PubMed ID: 18347813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
    Chau NG; Hotte SJ; Chen EX; Chin SF; Turner S; Wang L; Siu LL
    Ann Oncol; 2012 Jun; 23(6):1562-70. PubMed ID: 22080184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic therapies for salivary gland carcinomas: an overview of published clinical trials.
    Silva LC; Pérez-de-Oliveira ME; Pedroso CM; Leite AA; Santos-Silva AR; Lopes MA; Junior GD; Martins MD; Wagner VP; Kowalski LP; Squarize CH; Castilho RM
    Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e280-e287. PubMed ID: 38150606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways.
    Liu X; Wu H; Huang P; Zhang F
    J Oral Pathol Med; 2019 Jan; 48(1):43-51. PubMed ID: 30269363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic therapy in the management of metastatic or advanced salivary gland cancers.
    Lagha A; Chraiet N; Ayadi M; Krimi S; Allani B; Rifi H; Raies H; Mezlini A
    Oral Oncol; 2012 Oct; 48(10):948-957. PubMed ID: 22698431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of molecular analyses in adenoid cystic carcinomas of the salivary gland.
    Preisegger KH; Beham A; Kopp S; Jessernigg G; Gugl A; Stammberger H
    Onkologie; 2001 Jun; 24(3):273-7. PubMed ID: 11455221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.